Are cerebrovascular factors involved in Alzheimer's disease?

被引:64
|
作者
Kudo, T
Imaizumi, K
Tanimukai, H
Katayama, T
Sato, N
Nakamura, Y
Tanaka, T
Kashiwagi, Y
Jinno, Y
Tohyama, M
Takeda, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Clin Neurosci Psychiat, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan
[3] Tanabe Seiyaku Co Ltd, Yodogawa Ku, Osaka 5320031, Japan
关键词
Alzheimer's disease; cerebrovascular disorder; vascular dementia; risk factor; presenilin;
D O I
10.1016/S0197-4580(00)00129-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Recent epidemiological studies have shown that vascular risk factors may be involved in Alzheimer's disease (AD) as well as dementia in general. To investigate the relation between a vascular disorder and AD pathology, current criteria are defective because most depend on exclusion of a cerebrovascular disorder. Epidemiological studies have indicated the possibilities that arteriosclerosis, abnormal blood pressure, diabetes mellitus and smoking may be related to the pathogenesis of AD. As for the mechanism that vascular disorders influence AD, it is presumed that amyloid deposition may be caused by a vascular disorder. Alternatively, a vascular event may cause progression of subclinical AD to a clinical stage. Insulin resistance and apolipoprotein E may also be involved in these mechanisms. Our studies show that ischemia-induced the Alzheimer-associated gene presenilin 1 (PS1) and endoplasmic reticulum-stress, generated from a vascular disorder, may unmask clinical AD symptoms caused by presenilin mutation, suggesting that a vascular factor might be involved in the onset of familial AD. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 50 条
  • [31] The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients
    Yuan, Jing
    Wen, Ge
    Li, Yingjia
    Liu, Changxing
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 581 - 584
  • [32] Cerebrovascular Reactivity to Carbon Dioxide in Alzheimer's Disease
    Glodzik, Lidia
    Randall, Catherine
    Rusinek, Henry
    de Leon, Mony J.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (03) : 427 - 440
  • [33] Genes and mechanisms involved in β-amyloid generation and Alzheimer's disease
    Steiner, H
    Capell, A
    Leimer, U
    Haass, C
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 (06) : 266 - 270
  • [34] Sex differences in risk factors, burden, and outcomes of cerebrovascular disease in Alzheimer's disease populations
    Morrison, Cassandra
    Dadar, Mahsa
    Collins, Donald Louis
    ALZHEIMERS & DEMENTIA, 2024, 20 (01) : 34 - 46
  • [35] Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease
    Ji, Y
    Urakami, K
    Adachi, Y
    Maeda, M
    Isoe, K
    Nakashima, K
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1998, 9 (05) : 243 - 245
  • [36] Galantamine for the Treatment of BPSD in Thai Patients With Possible Alzheimer's Disease With or Without Cerebrovascular Disease
    Tangwongchai, S.
    Thavichachart, N.
    Senanarong, V.
    Poungvarin, N.
    Phanthumchinda, K.
    Praditsuwan, R.
    Nidhinandana, S.
    Chankrachang, S.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2008, 23 (06): : 593 - 601
  • [37] Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease
    Gallart-Palau, Xavier
    Lee, Benjamin S. T.
    Adav, Sunil S.
    Qian, Jingru
    Serra, Aida
    Park, Jung Eun
    Lai, Mitchell K. P.
    Chen, Christopher P.
    Kalaria, Raj N.
    Sze, Siu Kwan
    MOLECULAR BRAIN, 2016, 9
  • [38] Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD
    Erkinjuntti, T
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, : 14 - 23
  • [39] Is the Urea Cycle Involved in Alzheimer's Disease?
    Hansmannel, Franck
    Sillaire, Adeline
    Kamboh, M. Ilyas
    Lendon, Corinne
    Pasquier, Florence
    Hannequin, Didier
    Laumet, Geoffroy
    Mounier, Anais
    Ayral, Anne-Marie
    DeKosky, Steven T.
    Hauw, Jean-Jacques
    Berr, Claudine
    Mann, David
    Amouyel, Philippe
    Campion, Dominique
    Lambert, Jean-Charles
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 1013 - 1021
  • [40] Are the estrogen receptors involved in Alzheimer's disease?
    Lambert, JC
    Harris, JM
    Mann, D
    Lemmon, H
    Coates, J
    Cumming, A
    St-Clair, D
    Lendon, C
    NEUROSCIENCE LETTERS, 2001, 306 (03) : 193 - 197